ADO
Click for more information
0.00% 2.1¢ anteotech ltd

DCN - Clinical Study, page-14

  1. ds
    7,131 Posts.
    clock Created with Sketch.
    29/03/16
    23:34
    Post #: 17377749
    Does that mean you would share my view that having DiaSource and it's production and distribution channels would be a plus that we can 'jump the queue' so to speak by launching M&G fuelled diagnostics via DiaSource rather than have to convince any big pharma to integrate?
    ADO Price at posting: 4.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 19  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Gold potential soars at Black Swan with major anomalies discovered – Wilson's prospect shines
right-arrow Created with Sketch.
NEWS 190m antimony-copper intercept at Bulla Park – major mineralisation confirmed
right-arrow Created with Sketch.
NEWS Pepper delivers major high-grade gold discoveries – belt-scale potential confirmed
right-arrow Created with Sketch.
NEWS $140,000 in grant funding has been secured for drilling at Golden Ridge, with preparations underway for two exciting prospects
right-arrow Created with Sketch.
NEWS Uncover the potential at the Storm Project, where exceptional RC drill results reveal 22.9m at 8.5% Cu, indicating significant resource expansion beyond the Cyclone Deposit
right-arrow Created with Sketch.
RDN Preliminary interpretation of Andover South reveals key NE-trending corridor hosting lithium mineralization
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $52.28M
Open High Low Value Volume
2.1¢ 2.2¢ 2.0¢ $12.51K 612.0K

Buyers (Bids)

No. Vol. Price($)
9 1790998 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 32423 1
View Market Depth
Last trade - 16.10pm 27/09/2024 (20 minute delay) ?
ADO (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.